Advanced search
Publication Cover
Polycyclic Aromatic Compounds Volume 42, 2022 - Issue 7
Submit an article Journal homepage
162
Views
8
CrossRef citations to date
0
Altmetric
Research Articles

2-(Alkylthio)-3-(Naphthalen-1-yl)Quinazolin-4(3H)-Ones: Ultrasonic Synthesis, DFT and Molecular Docking Aspects

Farrhat F. Mohammeda Faculty of Science, Chemistry Department, Benghazi University, Bengazhi, Libya
,
Mohamad Hagarb Faculty of Science, Chemistry Department, Taibah University, Yanbu, Saudi Arabia;c Faculty of Science, Chemistry Department, Alexandria University, Alexandria, EgyptCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0003-0169-7738
ORCID Icon,
Shazia Parveenb Faculty of Science, Chemistry Department, Taibah University, Yanbu, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0002-2213-2958
ORCID Icon,
Rua B. Alnomanb Faculty of Science, Chemistry Department, Taibah University, Yanbu, Saudi Arabia
,
Hoda A. Ahmedd Faculty of Science, Department of Chemistry, Cairo University, Cairo, EgyptORCID Iconhttps://orcid.org/0000-0003-3966-7024
ORCID Icon,
El Sayed H. El Ashryc Faculty of Science, Chemistry Department, Alexandria University, Alexandria, EgyptCorrespondence[email protected] [email protected]
&
Hanaa A. Rasheedc Faculty of Science, Chemistry Department, Alexandria University, Alexandria, Egypt
 show all
Pages 4034-4048 | Received 21 Jul 2020, Accepted 15 Jan 2021, Published online: 01 Feb 2021

References

  • P. G. Mahajan, N. C. Dige, B. D. Vanjare, H. Raza, M. Hassan, S.-Y. Seo, C.-H. Kim, and K. H. Lee, “Facile Synthesis of New Quinazolinone Benzamides as Potent Tyrosinase Inhibitors: Comparative Spectroscopic and Molecular Docking Studies,” Journal of Molecular Structure 1198 (2019): 126915.
  • S. Gatadi, G. Pulivendala, J. Gour, S. Malasala, S. Bujji, R. Parupalli, M. Shaikh, C. Godugu, and S. Nanduri, “Synthesis and Evaluation of New 4(3H)-Quinazolinone Derivatives as Potential Anticancer Agents,” Journal of Molecular Structure 1200 (2020): 127097.
  • Y. Zhao, F. Liu, G. He, K. Li, C. Zhu, W. Yu, C. Zhang, M. Xie, J. Lin, J. Zhang, et al. “Discovery of Arylamide-5-Anilinoquinazoline-8-Nitro Derivatives as VEGFR-2 Kinase Inhibitors: Synthesis, In Vitro Biological Evaluation and Molecular Docking,” Bioorganic and Medicinal Chemistry Letters 29, no. 23 (2019): 126711.
  • M. Alizadeh-Kouzehrash, and A. Rahmati, “Synthesis of a Structure Containing Three N-Fused Heterocycles with Very High Bond-Forming through a One-Pot Reaction,” Tetrahedron 76, no. 7 (2020): 130923.
  • A. Deep, “Synthesis, Anti HIV and Anti-Infective Potential of Medicinal Important Heterocyclic Compounds,” Current Bioactive Compounds 15, no. 3 (2019): 270.
  • A. Ibrar, M. Kazmi, A. Khan, S. A. Halim, A. Saeed, S. Mehsud, A. Al-Harrasi, and I. Khan, “Robust Therapeutic Potential of Carbazole-Triazine Hybrids as a New Class of Urease Inhibitors: A Distinctive Combination of Nitrogen-Containing Heterocycles,” Bioorganic Chemistry 95 (2020): 103479.
  • A. Belyaev, Y.-T. Chen, Z.-Y. Liu, P. Hindenberg, C.-H. Wu, P.-T. Chou, C. Romero-Nieto, and I. O. Koshevoy, “Intramolecular Phosphacyclization: Polyaromatic Phosphonium P-Heterocycles with Wide-Tuning Optical Properties,” A European Journal Chemistry (Weinheim an der Bergstrasse, Germany) 25, no. 25 (2019): 6332–6341.
  • M. Krzeszewski, D. Gryko, and D. T. Gryko, “The Tetraarylpyrrolo[3,2-b] Pyrroles—From Serendipitous Discovery to Promising Heterocyclic Optoelectronic Materials,” Accounts of Chemical Research 50, no. 9 (2017): 2334–2345.
  • R. Wang, Y. Liang, G. Liu, and S. Pu, “Aggregation-Induced Emission Compounds Based on 9,10-Diheteroarylanthracene and Their Applications in Cell Imaging,” RSC Advances 10, no. 4 (2020): 2170–2179.
  • S. Tahlan, S. Kumar, and B. Narasimhan, “Pharmacological Significance of Heterocyclic 1H-Benzimidazole Scaffolds: A Review,” BMC Chemistry 13, no. 1 (2019): 101.
  • R. Teja, S. Kapu, S. Kadiyala, V. Dhanapal, and A. N. Raman, “Heterocyclic Systems Containing Bridgehead Nitrogen Atom: Synthesis and Antimicrobial Activity of Thiadiazolo[2′,3′:2,3]Imidazo[4,5-B]Quinoxaline,” Journal of Saudi Chemical Society 20 (2016): S387–S392.
  • X.-F. Shang, S. L. Morris-Natschke, Y.-Q. Liu, X. Guo, X.-S. Xu, M. Goto, J.-C. Li, G.-Z. Yang, and K.-H. Lee, “Biologically Active Quinoline and Quinazoline Alkaloids Part I,” Medical Research Review 38, no. 3 (2018): 775–828.
  • T. Herraiz, H. Guillén, V. J. Arán, and A. Salgado, “Identification, Occurrence and Activity of Quinazoline Alkaloids in Peganum Harmala,” Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 103 (2017): 261–269.
  • M. Bollini, A. M. Bruno, M. E. Niño, J. J. Casal, L. D. Sasiambarrena, D. A. G. Valdez, L. Battini, V. R. Puente, and M. E. Lombardo, “Synthesis, 2D-QSAR Studies and Biological Evaluation of Quinazoline Derivatives as Potent Anti-Trypanosoma Cruzi Agents,” Medicinal Chemistry (Shariqah (United Arab Emirates) 15, no. 3 (2019): 265–276. [30295191]
  • M. Mao, X. Zhang, B. Zhu, J. Wang, G. Wu, Y. Yin, and Q. Song, “Comparative Studies of Organic Dyes with a Quinazoline or Quinoline Chromophore as π-Conjugated Bridges for Dye-Sensitized Solar Cells,” Dyes and Pigments 124 (2016): 72–81.
  • J. Quinn, Y. He, D. A. Khan, J. Rasmussen, H. Patel, F. Haider, W. Kapadia, and Y. Li, “Synthesis, Characterization, and Air Stability Study of Pyrimido[4,5-g]Quinazoline-4,9-Dione-Based Polymers for Organic Thin Film Transistors,” RSC Advances 6, no. 82 (2016): 78477–78485.
  • J. T. E. Quinn, F. Haider, H. Patel, D. A. Khan, Z. Y. Wang, and Y. Li, “Ultrafast Photoresponse Organic Phototransistors Based on Pyrimido[4,5-g]Quinazoline-4,9-Dione Polymer,” Journal of Materials Chemistry C 5, no. 34 (2017): 8742–8748.
  • O. A. Alhaddad, H. A. Ahmed, and M. Hagar, “Experimental and Theoretical Approaches of New Nematogenic Chair Architectures of Supramolecular H-Bonded Liquid Crystals,” Molecules 25, no. 2 (2020): 365.
  • M. Hagar, H. A. Ahmed, and G. R. Saad, “New Calamitic Thermotropic Liquid Crystals of 2-Hydroxypyridine Ester Mesogenic Core: Mesophase Behaviour and DFT Calculations,” Liquid Crystals 47, no. 1 (2020): 114–124.
  • M. Hagar, K. Chaieb, S. Parveen, H. A. Ahmed, and R. B. Alnoman, “N-Alkyl 2-Pyridone versus O-Alkyl 2-Pyridol: Ultrasonic Synthesis, DFT, Docking Studies and Their Antimicrobial Evaluation,” Journal of Molecular Structure 1199 (2020): 126926.
  • M. Hagar, H. A. Ahmed, T. H. El-Sayed, and R. Alnoman, “Mesophase Behavior and DFT Conformational Analysis of New Symmetrical Diester Chalcone Liquid Crystals,” Journal of Molecular Liquids 285 (2019): 96–105.
  • S. S. Nafee, H. A. Ahmed, and M. Hagar, “Theoretical, Experimental and Optical Study of New Thiophene-Based Liquid Crystals and Their Positional Isomers,” Liquid Crystals 47, no. 9 (2020): 1291–1302.
  • S. S. Nafee, M. Hagar, H. A. Ahmed, O. A. Alhaddad, R. M. El-Shishtawy, and B. M. Raffah, “New Two Rings Schiff Base Liquid Crystals; Ball Mill Synthesis, Mesomorphic, Hammett and DFT Studies,” Journal of Molecular Liquids 299 (2020): 112161.
  • S. Nafee, M. Hagar, H. Ahmed, R. El-Shishtawy, and B. Raffah, “The Synthesis of New Thermal Stable Schiff Base/Ester Liquid Crystals: A Computational, Mesomorphic, and Optical Study,” Molecules 24, no. 17 (2019): 3032.
  • R. Alnoman, H. A. Ahmed, and M. Hagar. “Synthesis, Optical, and Geometrical Approaches of New Natural Fatty Acids’ Esters/Schiff Base Liquid Crystals,” Molecules 24, no. 23 (2019): 4293.
  • H. A. Ahmed, M. Hagar, and O. A. Alhaddad, “Mesomorphic and Geometrical Orientation Study of the Relative Position of Fluorine Atom in Some Thermotropic Liquid Crystal Systems,” Liquid Crystals 47, no. 3 (2020): 404–413.
  • R. B. Alnoman, S. Parveen, M. Hagar, H. A. Ahmed, and J. G. Knight, “A New Chiral Boron-Dipyrromethene (BODIPY)-Based Fluorescent Probe: Molecular Docking, DFT, Antibacterial and Antioxidant Approaches,” Journal of Biomolecular Structure and Dynamics 38, no. 18 (2020): 5429–5442.
  • J. Liu, J. You, S. Zhang, C. Song, Z. Ji, J. Zhuang, and Y. Yu, “New Fluorescent Labeling Reagent Benzimidazo[2,1-b]Quinazoline-12(6H)-One-5-Ethylimidazole Ester and its Application in the Analysis of Endocrine Disrupting Compounds in Milk by High Performance Liquid Chromatography with Fluorescence Detection,” Microchemical Journal 138 (2018): 309–315.
  • Y. Suzuki, J.-i. Sawada, P. Hibner, H. Ishii, K. Matsuno, M. Sato, B. Witulski, and A. Asai, “Fluorescent Anticancer Quinazolines as Molecular Probes for β-Tubulin Colchicine Site Competition Assay and Visualization of Microtubules as Intracellular Targeting Sites,” Dyes and Pigments 145 (2017): 233–238.
  • J. Yuan, Y. Yuan, X. Tian, Y. Liu, and J. Sun, “Insights into the Photobehavior of Fluorescent Oxazinone, Quinazoline, and Difluoroboron Derivatives: Molecular Design Based on the Structure–Property Relationships,” The Journal of Physical Chemistry C 121, no. 14 (2017): 8091–8108.
  • E. S. H. El Ashry, E. S. Ramadan, H. Abdel Hamid, and M. Hagar, “Microwave‐Assisted Synthesis of Quinoline Derivatives from Isatin,” Synthetic Communications 35, no. 17 (2005): 2243–2250.
  • T. El-Sayed, A. Aboelnaga, M. El-Atawy, and M. Hagar, “Ball Milling Promoted N-Heterocycles Synthesis,” Molecules 23, no. 6 (2018): 1348.
  • T. EL-Sayed, A. Aboelnaga, and M. Hagar, “Ball Milling Assisted Solvent and Catalyst Free Synthesis of Benzimidazoles and Their Derivatives,” Molecules 21, no. 9 (2016): 1111.
  • A. Aboelnaga, M. Hagar, and S. Soliman, “Ultrasonic Synthesis, Molecular Structure and Mechanistic Study of 1,3-Dipolar Cycloaddition Reaction of 1-Alkynylpyridinium-3-Olate and Acetylene Derivatives,” Molecules 21, no. 7 (2016): 848.
  • R. Cella, and H. A. Stefani, “Ultrasound in Heterocycles Chemistry,” Tetrahedron 65, no. 13 (2009): 2619–2641.
  • J. S. Yadav, B. V. S. Reddy, and K. S. Reddy, “Ultrasound-Accelerated Synthesis of Chiral Allylic Alcohols Promoted by Indium Metal,” Tetrahedron 59, no. 28 (2003): 5333–5336.
  • S. Wang, S. Ji, and X. Su, “A Meldrum’s Acid Catalyzed Synthesis of Bis (Indolyl) Methanes in Water Under Ultrasonic Condition,” Chinese Journal of Chemistry 26, no. 1 (2008): 22–24.
  • M. A. Pasha, and V. P. Jayashankara, “Reduction of Arylnitro Compounds to Azoarenes and/or Arylamines by Al/NaOH in Methanol Under Ultrasonic Conditions,” Ultrasonics Sonochemistry 12, no. 6 (2005): 433–435.
  • J.-T. Li, X.-L. Li, and T.-S. Li, “Synthesis of Oximes Under Ultrasound Irradiation,” Ultrasonics Sonochemistry 13, no. 3 (2006): 200–202.
  • R. S. Disselkamp, T. R. Hart, A. M. Williams, J. F. White, and C. H. F. Peden, “Ultrasound-Assisted Hydrogenation of Cinnamaldehyde,” Ultrasonics Sonochemistry 12, no. 4 (2005): 319–324.
  • A. Shaabani, and S. E. Hooshmand, “Diversity-Oriented Catalyst-Free Synthesis of Pseudopeptides Containing Rhodamine Scaffolds via a One-Pot Sequential Isocyanide-Based Six-Component Reactions in Water Using Ultrasound Irradiation,” Ultrasonics Sonochemistry 40, (2018): 84–90.
  • N. A. Abdel Hafez, H. M. E. Hassaneen, T. A. Farghaly, S. M. Riyadh, and H. S. A. Elzahabi, “Synthesis of New Bis-Spiropyrazoles as Antitumor Agents Under Ultrasound Irradiation,” Mini Reviews in Medicinal Chemistry 18, no. 7 (2018): 631–637.
  • G. Cravotto and P. Cintas, “Power Ultrasound in Organic Synthesis: Moving Cavitational Chemistry from Academia to Innovative and Large-Scale Applications,” Chemical Society Reviews 35, no. 2 (2006): 180–196.
  • T. J. Mason, A. J. Cobley, J. E. Graves, and D. Morgan, “New Evidence for the Inverse Dependence of Mechanical and Chemical Effects on the Frequency of Ultrasound,” Ultrasonics Sonochemistry 18, no. 1 (2011): 226–230.
  • M. Hagar, S. M. Soliman, F. Ibid, and E. S. H. El Ashry, “Quinazolin-4-yl-Sulfanylacetyl-Hydrazone Derivatives; Synthesis, Molecular Structure and Electronic Properties,” Journal of Molecular Structure 1049, (2013): 177–188.
  • D. Mahendiran, S. Amuthakala, N. S. P. Bhuvanesh, R. S. Kumar, and A. K. Rahiman, “Copper Complexes as Prospective Anticancer Agents: In Vitro and In Vivo Evaluation, Selective Targeting of Cancer Cells by DNA Damage and S Phase Arrest,” RSC Advances 8, no. 30 (2018): 16973–16990.
  • C. A. Lipinski, F. Lombardo, B. W. Dominy, and P. J. Feeney, “Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings,” Advanced Drug Delivery Reviews 23, no. 1–3 (1997): 3–25.
  • S. Parveen, and R. B. Alnoman, “Potential Exploration of Recent FDA-Approved Anticancer Drugs against Models of SARS-CoV-2’s Main Protease and Spike Glycoprotein: A Computational Study,” Biointerface Research in Applied Chemistry 11, no. 3 (2021): 10059–10073.
  • A. Husain, M. Bhutani, S. Parveen, S. A. Khan, A. Ahmad, and M. A. Iqbal. “Synthesis, In Vitro Cytotoxicity, ADME and Molecular Docking Studies of Benzimidazole Bearing Furanone Derivatives,” Journal of the Chinese Chemical Society (2020). 10.1002/jccs.202000130
  • S. Parveen, “In Silico Drug Repurposing of Fda-Approved Artemisinins as Potent Chemotherapeutics Targeting BCL-2, CDK-6 & VEGFR-2: Density Functional Exploration and Molecular Docking Study,” Biointerface Research in Applied Chemistry 11, no. 2 (2021): 9604–9618.
  • S. Parveen, R. B. Alnoman, M. Hagar, H. A. Ahmed, and J. G. Knight, “Synthesis, Molecular Docking, and DFT Calculation of a Half‐Strapped BODIPY as Potential EGFR Inhibitor,” Chemistry Select 5, no. 42 (2020): 13163–13173.
  • R. B. Alnoman, M. Hagar, S. Parveen, H. A. Ahmed, and J. G. Knight, “Computational and Molecular Docking Approaches of a New Axially Chiral BODIPY Fluorescent Dye,” Journal of Photochemistry and Photobiology A: Chemistry 395 (2020): 112508.
  • H. A. Mahdy, M. K. Ibrahim, A. M. Metwaly, A. Belal, A. B. M. Mehany, K. M. A. El-Gamal, A. El-Sharkawy, M. A. Elhendawy, M. M. Radwan, M. A. Elsohly, et al. “Design, Synthesis, Molecular Modeling, In Vivo Studies and Anticancer Evaluation of Quinazolin-4(3H)-One Derivatives as Potential VEGFR-2 Inhibitors and Apoptosis Inducers,” Bioorganic Chemistry 94 (2020): 103422.
  • L. Shi, T.-T. Wu, Z. Wang, J.-Y. Xue, and Y.-G. Xu, “Discovery of N-(2-Phenyl-1H-Benzo[d]imidazol-5-yl)Quinolin-4-Amine Derivatives as Novel VEGFR-2 Kinase Inhibitors,” European Journal of Medicinal Chemistry 84 (2014): 698–707.
  • P. Carmeliet, “Angiogenesis in Health and Disease,” Nature Medicine 9, no. 6 (2003): 653–660.
  • D. J. Hicklin, and L. M. Ellis, “Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis,” Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 23, no. 5 (2005): 1011–1027.
  • H.-Q. Zhang, F.-H. Gong, C.-G. Li, C. Zhang, Y.-J. Wang, Y.-G. Xu, and L.-P. Sun, “Design and Discovery of 4-Anilinoquinazoline-Acylamino Derivatives as EGFR and VEGFR-2 Dual TK Inhibitors,” European Journal of Medicinal Chemistry 109 (2016): 371–379.
  • P. Traxler, “Tyrosine Kinases as Targets in Cancer Therapy – Successes and Failures,” Expert Opinion on Therapeutic Targets 7, no. 2 (2003): 215–234.
  • I. Collins, and P. Workman, “Design and Development of Signal Transduction Inhibitors for Cancer Treatment: Experience and Challenges with Kinase Targets,” Current Signal Transduction Therapy 1, no. 1 (2006): 13–23.
  • D. Panigrahy, S. Singer, L. Q. Shen, C. E. Butterfield, D. A. Freedman, E. J. Chen, M. A. Moses, S. Kilroy, S. Duensing, C. Fletcher, et al. “PPARγ Ligands Inhibit Primary Tumor Growth and Metastasis by Inhibiting Angiogenesis,” Journal of Clinical Investigation 110, no. 7 (2002): 923–932.
  • H. A. Ibrahim, F. M. Awadallah, H. M. Refaat, and K. M. Amin, “Design, Synthesis and Molecular Modeling Study for Some New 2-Substituted Benzimidazoles as Dual Inhibitors for VEGFR-2 and c-Met,” Future Medicinal Chemistry 10, no. 5 (2018): 493–509.
  • O. Fedorov, S. Müller, and S. Knapp, “The (un)Targeted Cancer Kinome,” Nature Chemical Biology 6, no. 3 (2010): 166–169.
  • F. Zuccotto, E. Ardini, E. Casale, and M. Angiolini, “Through the "Gatekeeper Door": Exploiting the Active Kinase Conformation,” Journal of Medicinal Chemistry, 53, no. 7 (2010): 2681–2694.
  • L. Lintnerová, M. García-Caballero, F. Gregáň, M. Melicherčík, A. R. Quesada, J. Dobiaš, J. Lác, M. Sališová, and A. Boháč, “A Development of Chimeric VEGFR2 TK Inhibitor Based on Two Ligand Conformers from PDB: 1Y6A Complex-Medicinal Chemistry Consequences of a TKs Analysis,” European Journal of Medicinal Chemistry 72 (2014): 146–159.
  • J. Zhang, X. Jiang, Y. Jiang, M. Guo, S. Zhang, J. Li, J. He, J. Liu, J. Wang, L. Ouyang, et al. “Recent Advances in the Development of Dual VEGFR and c-Met Small Molecule Inhibitors as Anticancer Drugs,” European Journal of Medicinal Chemistry 108, (2016): 495–504.
  • Z. Zhao, H. Wu, L. Wang, Y. Liu, S. Knapp, Q. Liu, and N. S. Gray, “Exploration of Type II Binding Mode: A Privileged Approach for Kinase Inhibitor Focused Drug Discovery?” ACS Chemical Biology 9, no. 6 (2014): 1230–1241.
  • P. D. Lyne, M. L. Lamb, and J. C. Saeh, “Accurate Prediction of the Relative Potencies of Members of a Series of Kinase Inhibitors Using Molecular Docking and MM-GBSA Scoring,” Journal of Medicinal Chemistry 49, no. 16 (2006): 4805–4808.
  • G. Gece, “The Use of Quantum Chemical Methods in Corrosion Inhibitor Studies,” Corrosion Science 50, no. 11 (2008): 2981–2992.
  • M. J. Frisch, Gaussian 09, vol. 32 (Wallingford, CT: Gaussian, Inc., 2009), 5648–5652.
  • R. Dennington, T. Keith, and J. Millam, GaussView (version 5) (2009).
  • G. Macindoe, L. Mavridis, V. Venkatraman, M.-D. Devignes, and D. W. Ritchie, “HexServer: An FFT-Based Protein Docking Server Powered by Graphics Processors,” Nucleic Acids Research 38, no. Web Server Issue (2010): W445–W449.
  • D. Mustard, and D. W. Ritchie, “Docking Essential Dynamics Eigenstructures,” Proteins 60, no. 2 (2005): 269–274.
  • M. McTigue, B. W. Murray, J. H. Chen, Y.-L. Deng, J. Solowiej, and R. S. Kania, “Molecular Conformations, Interactions, and Properties Associated with Drug Efficiency and Clinical Performance among VEGFR TK Inhibitors,” Proceedings of the National Academy of Sciences of the United States of America 109, no. 45 (2012): 18281–18289.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.